logo-large
  • Browse Categories

Publications by authors named "Toru Inakawa"

Claim this Profile
O
Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 Trial.
Kazutaka Nakamura, Yuki Kobari, Yudai Ishiyama, Hanae Kondo, Toru Inakawa

In Vivo· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience.
Yudai Ishiyama, Toru Inakawa, Maki Yoshino, Koichi Nishimura, Toshihide Horiuchi

Anticancer Res· July 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Cabozantinib for Papillary Compared With Clear-cell Renal Cell Carcinoma Following Immune Checkpoint Inhibitor Treatment.
Hidekazu Tachibana, Toru Inakawa, Yuki Nemoto, Hiroki Ishihara, Hironori Fukuda

Anticancer Res· June 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: